Halda Doses 1st Patient In Ph 1/2 HLD-0915 Trial For Prostate Cancer
24 Feb 2025 //
BUSINESSWIRE
Halda Therapeutics To Present At 43rd Annual JP Morgan Conference
07 Jan 2025 //
BUSINESSWIRE
Halda Therapeutics Raises $126M For RIPTAC Cancer Therapies
12 Aug 2024 //
BUSINESSWIRE
Halda Therapeutics Publishes RIPTAC™ Proof-Of-Mechanism For Cancer Treatment
07 Aug 2024 //
BUSINESSWIRE
Halda Therapeutics Presents Preclinical Data for RIPTAC™ Therapeutics
17 Apr 2023 //
BUSINESSWIRE